American Portfolios Advisors’s Immunogen Inc IMGN Stock Holding History

American Portfolios Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$239	Hold	50	–	–	﹤0.01%	3450
2022 Q2	$225	Hold	50	–	–	﹤0.01%	3460
2022 Q1	$238	Hold	50	–	–	﹤0.01%	3521
2021 Q4	$371	Hold	50	–	–	﹤0.01%	3437
2021 Q3	$284	Hold	50	–	–	﹤0.01%	3416
2021 Q2	$330	Hold	50	–	–	﹤0.01%	3343
2021 Q1	$405	Hold	50	–	–	﹤0.01%	3218
2020 Q4	$323	Hold	50	–	–	﹤0.01%	2924
2020 Q3	$180	Hold	50	–	–	﹤0.01%	2901
2020 Q2	$230	Hold	50	–	–	﹤0.01%	2799
2020 Q1	$171	Hold	50	–	–	﹤0.01%	2722
2019 Q4	$255	Hold	50	–	–	﹤0.01%	2776
2019 Q3	$121	Hold	50	–	–	﹤0.01%	2781
2019 Q2	$109	Hold	50	–	–	﹤0.01%	2700
2019 Q1	$136	Hold	50	–	–	﹤0.01%	2575
2018 Q4	$240	Hold	50	–	–	﹤0.01%	2344
2018 Q3	$474	Hold	50	–	–	﹤0.01%	2344
2018 Q2	$487	Hold	50	–	–	﹤0.01%	2316
2018 Q1	$526	Hold	50	–	–	﹤0.01%	2241
2017 Q4	$321	Buy	+50	New	+$308	﹤0.01%	2210

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Portfolios Advisors's IMGN Position: Q3 2022 in Review

American Portfolios Advisors held its Immunogen Inc (IMGN) position steady in Q3 2022 at 50 shares worth $239. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

American Portfolios Advisors first reported a position in IMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $526 in Q1 2018. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

American Portfolios Advisors held 50 shares of Immunogen Inc worth $239 as of Q3 2022.
American Portfolios Advisors left its Immunogen Inc share count unchanged in Q3 2022.
Immunogen Inc made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3450 holding.
American Portfolios Advisors first reported a position in Immunogen Inc in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Immunogen Inc position peaked at $526 in Q1 2018.
222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.